Literature DB >> 16696834

Aripiprazole use in a pregnant schizoaffective woman.

D N Mendhekar1, Keerthy R Sunder, Chittaranjan Andrade.   

Abstract

BACKGROUND: There are few or no clinical data on the safety of aripiprazole during pregnancy and lactation. CASE REPORT: A 27-year-old schizoaffective woman conceived while receiving aripiprazole 15 mg/day. The drug was withdrawn during the eighth week of gestation. She relapsed at week 20, and resumed treatment with the drug at a dose of 10 mg/day. She responded well, and the drug was continued through the rest of the pregnancy. The pregnancy was uneventful, but unexplained fetal tachycardia necessitated a cesarean section at full term. The newborn infant was normal in all regards and developed normally during a 6-month follow up. The infant required to be bottle-fed because of a failure of lactation.
CONCLUSION: In this case, exposure to aripiprazole during different trimesters of pregnancy was not associated with intrauterine death, morphological teratogenicity, impaired fetal growth, neonatal toxicity, or neurobehavioral teratogenicity. Maternal health was not adversely affected during pregnancy. However, lactation failure occurred after delivery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16696834     DOI: 10.1111/j.1399-5618.2006.00316.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  9 in total

Review 1.  Antipsychotic therapy during early and late pregnancy. A systematic review.

Authors:  Salvatore Gentile
Journal:  Schizophr Bull       Date:  2008-09-11       Impact factor: 9.306

2.  Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study.

Authors:  Pierre-Michel Llorca; Philippe Nuss; Éric Fakra; Isabelle Alamome; Dominique Drapier; Wissam El Hage; Renaud Jardri; Stéphane Mouchabac; Marc Rabbani; Nicolas Simon; Marie-Noëlle Vacheron; Jean-Michel Azorin
Journal:  BMC Psychiatry       Date:  2022-05-28       Impact factor: 4.144

Review 3.  Perinatal depression: treatment options and dilemmas.

Authors:  Teri Pearlstein
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

Review 4.  Prolactin serum concentrations during aripiprazole treatment in youth.

Authors:  Daniel J Safer; Chadi A Calarge; Alan M Safer
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-05-06       Impact factor: 2.576

5.  Pregnancy outcomes following maternal exposure to second-generation antipsychotics given with other psychotropic drugs: a cohort study.

Authors:  Alexander Sadowski; Michelle Todorow; Parvaneh Yazdani Brojeni; Gideon Koren; Irena Nulman
Journal:  BMJ Open       Date:  2013-07-13       Impact factor: 2.692

Review 6.  Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges.

Authors:  Richard A Epstein; Katherine M Moore; William V Bobo
Journal:  Drug Healthc Patient Saf       Date:  2014-12-24

Review 7.  Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis.

Authors:  Eline M P Poels; Lisanne Schrijver; Astrid M Kamperman; Manon H J Hillegers; Witte J G Hoogendijk; Steven A Kushner; Sabine J Roza
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-06-11       Impact factor: 4.785

8.  Molecular mechanisms underlying electroconvulsive therapy-induced amnestic deficits: A decade of research.

Authors:  Chittaranjan Andrade
Journal:  Indian J Psychiatry       Date:  2008-10       Impact factor: 1.759

Review 9.  Mood stabilizers in pregnancy and lactation.

Authors:  Sandeep Grover; Ajit Avasthi
Journal:  Indian J Psychiatry       Date:  2015-07       Impact factor: 1.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.